期刊文献+

阿片类生长因子受体抑制雄激素依赖性前列腺癌LNCaP细胞的生长 被引量:1

Opioid growth factor receptor depresses growth of androgen-dependent prostate cancer LNCaP cells
下载PDF
导出
摘要 目的:观察阿片类生长因子受体(opioid growth factor receptor,OGFr)对雄激素依赖性前列腺癌LNCaP细胞活力的影响。方法:将LNCaP细胞随机分为非转染组、空白质粒组(转染pcDNA3.1空白质粒)和OGFr质粒组(转染表达质粒pcDNA3.1-OGFr),RT-qPCR和Western blot检测转染效率;10 nmol/L二氢睾酮(dihydrotestosterone,DHT)分别处理LNCaP细胞24、48、72和96 h后,CCK-8法检测细胞活力,流式细胞术检测细胞周期及凋亡的变化,RT-qPCR和Western blot检测细胞周期调控蛋白——细胞周期蛋白依赖性激酶2(cyclin-dependent kinase 2,CDK2)、细胞周期蛋白E(cyclin E)和p21的表达。结果:相对于非转染组,pcDNA3.1-OGFr转染显著增加LNCaP细胞OGFr的mRNA和蛋白表达(P<0.05);10 nmol/L DHT呈时间依赖性促进LNCaP细胞的活力(P<0.05),而DHT对OGFr质粒组细胞活力的增强效应显著降低(P<0.05);在DHT的作用下,OGFr质粒组细胞发生G_(0)/G_(1)期阻滞(P<0.05),但细胞凋亡率无显著差异;CDK2表达下调(P<0.05),p21表达上调(P<0.05),而cyclin E表达无显著差异。结论:OGFr诱导的细胞周期阻滞可抑制雄激素DHT对人前列腺癌LNCaP细胞的生长效应。 AIM:To investigate the effect of opioid growth factor receptor(OGFr)on the growth of androgendependent human prostate cancer LNCaP cells.METHODS:Cultured LNCaP cells were randomly divided into nontransfection group,pcDNA3.1 empty plasmid group and pcDNA3.1-OGFr group.Transfection efficiency was evaluated by RTqPCR and Western blot analysis.The viability of LNCaP cells was measured by CCK-8 assay in the presence of 10 nmol/L dihydrotestosterone(DHT)at different time points(24,48,72 and 96 h).Cell cycle and apoptosis were examined by flow cytometry,and the expression of cyclin-dependent kinase 2(CDK2),cyclin E and p21 at mRNA and protein levels were determined by RT-qPCR and Western blot.RESULTS:The mRNA and protein levels of OGFr exhibited a marked increase in pcDNA3.1-OGFr group compared with nontransfection group(P<0.05).Treatment with 10 nmol/L DHT promoted the viability of LNCaP cells in a time-dependent manner(P<0.05).However,the effect of DHT on LNCaP cell viability was partly abolished in pcDNA3.1-OGFr group(P<0.05).The LNCaP cells with OGFr over-expression exhibited significant blockage in G_(0)/G_(1) phase in the presence of 10 nmol/L DHT(P<0.05),but no effect on apoptosis.Furthermore,the expression of CDK2 at mRNA and protein levels in pcDNA3.1-OGFr group was decreased(P<0.05),p21 expression was increased(P<0.05),and no detectable expression change in cyclin E was found.CONCLUSION:OGFrinduced cell cycle arrest has a potent inhibitory effect on DHT-induced growth of human prostate cancer LNCaP cells.
作者 张志发 朱梦娇 周志强 王学仁 ZHANG Zhi-fa;ZHU Meng-jiao;ZHOU Zhi-qiang;WANG Xue-ren(Department of Anesthesiology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China)
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2021年第2期263-268,共6页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.81371251) 湖北陈孝平科技发展基金“肝胆胰恶性肿瘤研究基金” 华中科技大学自主创新研究基金资助项目(No.2016YXMS122)。
关键词 阿片类生长因子受体 二氢睾酮 前列腺癌 细胞周期 细胞活力 Opioid growth factor receptor Dihydrotestosterone Prostatic cancer Cell cycle Cell viability
  • 相关文献

参考文献1

二级参考文献13

  • 1Manser E, Leung T, Salihuddin H, et al. A brain serine/ threonine protein kinase activated by Cdc42 and Racl [J]. Nature, 1994, 367(6458) :40-46.
  • 2Ye DZ, Field J. PAK signaling in cancer [ J ]. Cell Logist, 2012, 2(2) :105-116.
  • 3Hofmann C, Shepelev M, Chemoff J. The genetics of Pak [J]. J Cell Sci, 2004, 117(Pt 19) :4343-4354.
  • 4Jakobi R, Moertl E, Koeppel MA. p21-activated protein kinase gamma-PAK suppresses programmed cell death of BALB3T3 fibroblasts [J]. J Biol Chem, 2001,276(20) : 16624-16634.
  • 5Menges CW, Sementino E, Talarchek J, et al. Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways [J]. Mol Cancer Res, 2012, 10(9) :1178-1188.
  • 6Jakobi R, McCarthy CC, Koeppel MA, et al. Caspase-activated PAK-2 is regulated by subcellular targeting and proteasomal degradation [J]. J Biol Chem, 2003, 278 (40) : 38675-38685.
  • 7Wennerberg K, Rossman KL, Der CJ. The Ras superfamily at a glance EJ]. J Cell Sci, 2005, 118(Pt 5) :843-846.
  • 8Rossman KL, Der C J, Sondek J. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors [J]. Nat Rev Mol Cell Biol, 2005, 6(2) :167-180.
  • 9Rudel T, Bokoch GM. Membrane and morphological changes in apoptotie cells regulated by caspase-mediated activation of PAK2 [J]. Science, 1997, 276(5318) :1571- 1574.
  • 10Kumar R, Gururaj AE, Barnes CJ. p21-activated kinases in cancer [J]. Nat Rev Cancer, 2006, 6(6) :459-471.

共引文献3

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部